NORTHERN TRUST CORP - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$326,000
-27.2%
273,233
+10.0%
0.00%
Q2 2022$448,000
-80.1%
248,408
-77.7%
0.00%
Q1 2022$2,248,000
-28.9%
1,112,586
-4.6%
0.00%
-100.0%
Q4 2021$3,161,000
-37.1%
1,166,363
+3.4%
0.00%0.0%
Q3 2021$5,029,000
-19.1%
1,127,648
+5.2%
0.00%0.0%
Q2 2021$6,219,000
-9.1%
1,072,209
+10.0%
0.00%0.0%
Q1 2021$6,845,000
+46.5%
974,926
+0.1%
0.00%0.0%
Q4 2020$4,672,000
-20.3%
973,476
-3.2%
0.00%0.0%
Q3 2020$5,865,000
-13.1%
1,005,963
+0.6%
0.00%
-50.0%
Q2 2020$6,746,000
+53.1%
999,488
+44.2%
0.00%
+100.0%
Q1 2020$4,407,000
-33.3%
692,980
+9.3%
0.00%0.0%
Q4 2019$6,611,000
+167.1%
634,225
+0.7%
0.00%0.0%
Q3 2019$2,475,000
-73.5%
629,717
+0.2%
0.00%
-50.0%
Q2 2019$9,350,000
-40.0%
628,766
+0.1%
0.00%
-50.0%
Q1 2019$15,588,000
+39.0%
628,025
+0.6%
0.00%
+33.3%
Q4 2018$11,215,000
-38.8%
624,455
+0.1%
0.00%
-25.0%
Q3 2018$18,329,000
-34.1%
624,102
+2.1%
0.00%
-42.9%
Q2 2018$27,803,000
-5.7%
611,459
+9.5%
0.01%
-12.5%
Q1 2018$29,472,000
-22.4%
558,193
+0.0%
0.01%
-20.0%
Q4 2017$37,957,000
-19.6%
558,175
-2.5%
0.01%
-16.7%
Q3 2017$47,195,000
-4.5%
572,755
+8.6%
0.01%
-14.3%
Q2 2017$49,398,000
+59.5%
527,608
+8.5%
0.01%
+55.6%
Q1 2017$30,969,000
+65.3%
486,400
+15.3%
0.01%
+50.0%
Q4 2016$18,734,000
+27.7%
421,756
+3.7%
0.01%
+20.0%
Q3 2016$14,667,000
+174.0%
406,813
+4.2%
0.01%
+150.0%
Q2 2016$5,353,000
-21.6%
390,230
+14.3%
0.00%0.0%
Q1 2016$6,826,000
-41.3%
341,336
+2.7%
0.00%
-50.0%
Q4 2015$11,630,000
-61.1%
332,299
+2.1%
0.00%
-60.0%
Q3 2015$29,933,000
+20.0%
325,497
+14.7%
0.01%
+25.0%
Q2 2015$24,941,000
+14.8%
283,812
-3.1%
0.01%
+14.3%
Q1 2015$21,733,000
+34.6%
292,785
+1.6%
0.01%
+40.0%
Q4 2014$16,141,000
+19.8%
288,231
-3.0%
0.01%
+25.0%
Q3 2014$13,476,000
+25.1%
297,108
+14.2%
0.00%
+33.3%
Q2 2014$10,769,000
-42.4%
260,070
-3.6%
0.00%
-50.0%
Q1 2014$18,683,000
+7.8%
269,720
-6.2%
0.01%0.0%
Q4 2013$17,329,000
+17.7%
287,532
+18.8%
0.01%
+20.0%
Q3 2013$14,719,000
+2.5%
242,083
+12.9%
0.01%0.0%
Q2 2013$14,363,000214,4530.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders